Lung transplantation for pulmonary vascular disease Eric N Mendeloff, MD, Bryan F Meyers, MD, Thoralf M Sundt, MD, Tracey J Guthrie, BSN, Stuart C Sweet, MD, Maite de la Morena, MD, Steve Shapiro, MD, David T Balzer, MD, Elbert P Trulock, MD, John P Lynch, MD, Michael K Pasque, MD, Joel D Cooper, MD, Charles B Huddleston, MD, G.Alexander Patterson, MD The Annals of Thoracic Surgery Volume 73, Issue 1, Pages 209-219 (January 2002) DOI: 10.1016/S0003-4975(01)03082-X
Fig 1 (A) Preoperative and postoperative mean pulmonary artery pressures (PAMs) for single lung transplant (SLT) and bilateral lung transplant (BLT). (B) Preoperative and postoperative pulmonary vascular resistance (PVR) for SLT and BLT. (C) Preoperative and postoperative right ventricular ejection fractions (RVEFs) percent for SLT and BLT. The Annals of Thoracic Surgery 2002 73, 209-219DOI: (10.1016/S0003-4975(01)03082-X)
Fig 2 (A) Freedom from obliterative bronchiolitis posttransplantation (n = 100). (B) Freedom from obliterative bronchiolitis posttransplantation by type of allograft received. (BLT = bilateral lung transplant; SLT = single lung transplant.) The Annals of Thoracic Surgery 2002 73, 209-219DOI: (10.1016/S0003-4975(01)03082-X)
Fig 3 (A) Survival after thoracic transplantation for pulmonary hypertension (n = 100). (B) Survival after thoracic transplantation for pulmonary hypertension stratified by type of allograft received. (BLT = bilateral lung transplant; HLT = heart-lung transplant; SLT = single lung transplant.) The Annals of Thoracic Surgery 2002 73, 209-219DOI: (10.1016/S0003-4975(01)03082-X)